Bepotastine besilate
Tier C — Watch / tradeBepotastine besilate
Targets：HRH1
Brand：Bepomax, Talion, Bepreve
Indications (approved)：Allergic rhinitis, Urticaria, 痒疹, Allergic conjunctivitis, Perennial allergic rhinitis, Infectious skin disease
Regional status
Synthetic routes & intermediates4 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| BEPO-003 | 125602-69-9 | ethyl 4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate |
| BEPO-001 | 122368-54-1 | 2-((4-chlorophenyl)(piperidin-4-yloxy)methyl)pyridine |
| BEPO-002 | 2969-81-5 | ethyl 4-bromobutanoate |
| Code | CAS No. | Intermediate |
|---|---|---|
| BEPO-001 | 122368-54-1 | 2-((4-chlorophenyl)(piperidin-4-yloxy)methyl)pyridine |
| BEPO-002 | 2969-81-5 | ethyl 4-bromobutanoate |
| BEPO-004 | 201594-84-5 | (S)-2-((4-chlorophenyl)(piperidin-4-yloxy)methyl)pyridine |
| BEPO-005 | 190730-39-3 | (S)-ethyl 4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate |
| BEPO-006 | 125602-71-3 | (S)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid |
| BEPO-007 | 1998-11-3 | benzenesulfonic acid |
| Code | CAS No. | Intermediate |
|---|---|---|
| BEPO-001 | 122368-54-1 | 2-((4-chlorophenyl)(piperidin-4-yloxy)methyl)pyridine |
| BEPO-006 | 125602-71-3 | (S)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid |
| BEPO-007 | 1998-11-3 | benzenesulfonic acid |
| BEPO-008 | 4635-59-0 | 4-chlorobutanoyl chloride |
| BEPO-009 | 89-78-1Available | (1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol |
| BEPO-010 | 1092777-14-4 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 4-bromobutanoate |
| BEPO-011 | 1092777-17-7 | (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 4-(4-((S)-(4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate |
| BEPO-012 | 5382-16-1 | piperidin-4-ol |
| BEPO-013 | 4045-22-1 | 1-(4-hydroxypiperidin-1-yl)ethanone |
| BEPO-014 | 142404-69-1 | 2-(chloro(4-chlorophenyl)methyl)pyridine |
| Code | CAS No. | Intermediate |
|---|---|---|
| BEPO-015 | 6318-51-0 | (4-chlorophenyl)(pyridin-2-yl)methanone |
| BEPO-016 | 176022-47-2 | (S)-(4-chlorophenyl)(pyridin-2-yl)methanol |
| BEPO-017 | 1401242-42-9 | (S)-(4-chlorophenyl)(pyridin-2-yl)methyl 2,2,2-trichloroacetimidate |
| BEPO-018 | 451455-64-4 | ethyl 4-(4-hydroxypiperidin-1-yl)butanoate |
Frequently asked questions
What are the approved indications of Bepotastine besilate?
Approved indications include: Allergic rhinitis, Urticaria, 痒疹, Allergic conjunctivitis, Perennial allergic rhinitis, Infectious skin disease.
When does the Bepotastine besilate patent expire?
No public expiry year is available for Bepotastine besilate yet; this page updates once verified.
How many synthesis routes are recorded for Bepotastine besilate?
4 synthesis routes are recorded; the shortest is 2 steps with 0.86 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Bepotastine besilate intermediates?
1 intermediate CAS of Bepotastine besilate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Bepotastine besilate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27